77 related articles for article (PubMed ID: 8991954)
1. Niruriside, a new HIV REV/RRE binding inhibitor from Phyllanthus niruri.
Qian-Cutrone J; Huang S; Trimble J; Li H; Lin PF; Alam M; Klohr SE; Kadow KF
J Nat Prod; 1996 Feb; 59(2):196-9. PubMed ID: 8991954
[TBL] [Abstract][Full Text] [Related]
2. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
3. An anti-apoptotic protein, Hax-1, inhibits the HIV-1 rev function by altering its sub-cellular localization.
Modem S; Reddy TR
J Cell Physiol; 2008 Jan; 214(1):14-9. PubMed ID: 17929250
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
Luedtke NW; Tor Y
Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
[TBL] [Abstract][Full Text] [Related]
5. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
Nam YS; Petrovic A; Jeong KS; Venkatesan S
J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Rev can specifically interact with MMTV RNA and upregulate gene expression.
Dangerfield JA; Hohenadl C; Egerbacher M; Kodajova P; Salmons B; Günzburg WH
Gene; 2005 Sep; 358():17-30. PubMed ID: 16023306
[TBL] [Abstract][Full Text] [Related]
7. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
Urcuqui-Inchima S; Castaño ME; Hernandez-Verdun D; St-Laurent G; Kumar A
Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of mismatch-binding ligands as inhibitors for Rev-RRE interaction.
Nakatani K; Horie S; Goto Y; Kobori A; Hagihara S
Bioorg Med Chem; 2006 Aug; 14(15):5384-8. PubMed ID: 16603366
[TBL] [Abstract][Full Text] [Related]
9. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
[TBL] [Abstract][Full Text] [Related]
10. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
Luedtke NW; Liu Q; Tor Y
Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
[TBL] [Abstract][Full Text] [Related]
11. HIV inhibitory natural products. 26. Quinoline alkaloids from Euodia roxburghiana.
McCormick JL; McKee TC; Cardellina JH; Boyd MR
J Nat Prod; 1996 May; 59(5):469-71. PubMed ID: 8778237
[TBL] [Abstract][Full Text] [Related]
12. Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region.
Wang Y; Hamasaki K; Rando RR
Biochemistry; 1997 Jan; 36(4):768-79. PubMed ID: 9020774
[TBL] [Abstract][Full Text] [Related]
13. Defective rev response element (RRE) and rev gene in HAART treated AIDS patients with discordance between viral load and CD4+ T-cell counts.
Saurya S; Lichtenstein Z; Karpas A
J Clin Virol; 2005 Aug; 33(4):324-7. PubMed ID: 16005679
[TBL] [Abstract][Full Text] [Related]
14. A dynamic in vivo view of the HIV-I Rev-RRE interaction.
Charpentier B; Stutz F; Rosbash M
J Mol Biol; 1997 Mar; 266(5):950-62. PubMed ID: 9086273
[TBL] [Abstract][Full Text] [Related]
15. A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev.
Fang J; Kubota S; Yang B; Zhou N; Zhang H; Godbout R; Pomerantz RJ
Virology; 2004 Dec; 330(2):471-80. PubMed ID: 15567440
[TBL] [Abstract][Full Text] [Related]
16. Prenylcoumarin with Rev-export inhibitory activity from Cnidii Monnieris Fructus.
Tamura S; Fujitani T; Kaneko M; Murakami N
Bioorg Med Chem Lett; 2010 Jun; 20(12):3717-20. PubMed ID: 20493693
[TBL] [Abstract][Full Text] [Related]
17. Binding kinetics and bioassay of RRE mRNA fragments to a peptide containing the recognition domain of HIV-1 Rev.
West ML; Ramsdale TE
Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):85-8. PubMed ID: 9575345
[TBL] [Abstract][Full Text] [Related]
18. Analysis of intracellular trafficking and interactions of cytoplasmic HIV-1 Rev mutants in living cells.
Stauber RH; Afonina E; Gulnik S; Erickson J; Pavlakis GN
Virology; 1998 Nov; 251(1):38-48. PubMed ID: 9813201
[TBL] [Abstract][Full Text] [Related]
19. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
Sugaya M; Nishino N; Katoh A; Harada K
J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
[TBL] [Abstract][Full Text] [Related]
20. Modulation of HTLV-I gene expression by HIV-1 Rev through an alternative RxRE-independent pathway mediated by the RU5 portion of the 5'-LTR.
Kubota S; Furuta RA; Hatanaka M; Pomerantz RJ
Biochem Biophys Res Commun; 1998 Feb; 243(1):79-85. PubMed ID: 9473483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
